Physician profile
Ana Sofia Devaney
NPI 1639552086
$2,509.71
in general payments reported to CMS, 2019-2025
17 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $392 · 2023: $311 · 2024: $337 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,672.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $651.93 | 2022-2025 | Apretude |
| Gilead Sciences, INC. | $466.79 | 2023-2025 | Yeztugo |
| Abbvie INC. | $180.14 | 2021-2023 | |
| Lilly USA, LLC | $146.11 | 2021-2025 | Zepbound |
| Exact Sciences Corporation | $145.39 | 2023-2025 | Cologuard Collection Kit |
| Indivior INC. | $141.55 | 2021-2025 | Sublocade |
| Organon LLC | $134.43 | 2021-2024 | Nexplanon |
| Pfizer INC. | $127.45 | 2023-2025 | |
| Amgen INC. | $115.45 | 2021 | |
| Glaxosmithkline, LLC. | $112.97 | 2021-2025 | Bexsero, Pediarix, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $69.62 | 2021-2024 | |
| Novo Nordisk INC | $69.37 | 2021-2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.93 | 2024-2025 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $40.03 | 2021-2022 | |
| Dexcom, INC. | $30.33 | 2024 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.74 | 2025 | |
| Evofem Biosciences, INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Devaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.